VABYSMO

Google image searchProduct monograph

Active ingredient

faricimab, 6 MG/0.05 ML

DIN: 02527618

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVITREAL

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 18-JUL-2022

ATC:

• S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
• S01L — OCULAR VASCULAR DISORDER AGENTS (ATC, ATC/DDD)
• S01LA — Antineovascularisation agents (ATC, ATC/DDD)
• S01LA09 — FARICIMAB (ATC/DDD)

External Links for Vabysmo

Search on Google

• Vabysmo side effects
• Vabysmo dosage
• faricimab side effects
• faricimab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find vabysmo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.